Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis

This trial is testing a special skin gel made from bacterial cellulose and a natural antimicrobial compound (monolaurin) to help prevent or treat radiation-related skin irritation (acute radiation dermatitis) in breast cancer patients receiving radiation after mastectomy. **You may be eligible if...** - You are female (assigned female at birth), 18 or older - You have been diagnosed with breast cancer and have already completed mastectomy and chemotherapy - You are scheduled to receive hypo-fractionated radiation therapy after mastectomy - Your general health is good (ECOG 0–1) **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have had prior chest or breast radiation - You have a history of another cancer - You have connective tissue disease, active skin conditions in the radiation area, or uncontrolled chronic diseases - You have a known allergy to any component of the gels being tested Talk to your doctor to see if this trial is right for you.